J. Hernández

Dr. J. Hernández


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PGPeter Goldstraw
Peter Goldstraw
KCKari Chansky
Kari Chansky
JCJohn Crowley
John Crowley
RRRamon Rami-Porta
Ramon Rami-Porta
HAHisao Asamura
Hisao Asamura
KYK. Yokoi
K. Yokoi

31 July 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FPFrancisco Pozo-Rodríguez
Francisco Pozo-Rodríguez
Jose Luis Lopez-CamposJose Luis Lopez-Campos
Jose Luis Lopez-Campos
CÁCarlos J. Álvarez-Martínez
Carlos J. Álvarez-Martínez
ACAdy Castro-Acosta
Ady Castro-Acosta
RARamón Agüero
Ramón Agüero
NANisa Boukichou Abdelkader
Nisa Boukichou Abdelkader
AUDIPOC is a nationwide clinical audit that describes the characteristics, interventions and outcomes of patients admitted to Spanish hospitals because of an exacerbation of chronic obstructive pulmonary disease (ECOPD), assessing the compliance of these parameters with current international guidelines. The present study describes hospital resources, hospital factors related to case recruitment variability, patients’ characteristics, and adherence to guidelines. An organisational database was completed by all participant hospitals recording resources and organisation. Over an 8-week period 11,564 consecutive ECOPD admissions to 129 Spanish hospitals covering 70% of the Spanish population were prospectively identified. At hospital discharge, 5,178 patients (45% of eligible) were finally included, and thus constituted the audited population. Audited patients were reassessed 90 days after admission for survival and readmission rates. A wide variability was observed in relation to most variables, hospital adherence to guidelines, and readmissions and death. Median inpatient mortality was 5% (across-hospital range 0–35%). Among discharged patients, 37% required readmission (0–62%) and 6.5% died (0–35%). The overall mortality rate was 11.6% (0–50%). Hospital size and complexity and aspects related to hospital COPD awareness were significantly associated with case recruitment. Clinical management most often complied with diagnosis and treatment recommendations but rarely (<50%) addressed guidance on healthy life-styles. The AUDIPOC study highlights the large across-hospital variability in resources and organization of hospitals, patient characteristics, process of care, and outcomes. The study also identifies resources and organizational characteristics associated with the admission of COPD cases, as well as aspects of daily clinical care amenable to improvement.

6 June 2019 in Clinical and Translational Oncology
Verified
Journal Article
Open access
PDF file
MMMargarita Majem
Margarita Majem
JHJ. Hernández
J. Hernández
FHF. Hernando-Trancho
F. Hernando-Trancho
NDN. Rodríguez de Dios
N. Rodríguez de Dios
ASA. Sotoca
A. Sotoca
MPM. Provencio
M. Provencio
Stage III non-small cell lung cancer (NSCLC) is a very heterogeneous disease that encompasses patients with resected, potentially resectable and unresectable tumours. To improve the prognostic capacity of the TNM classification, it has been agreed to divide stage III into sub-stages IIIA, IIIB and IIIC that have very different 5-year survival rates (36, 26 and 13%, respectively). Currently, it is considered that both staging and optimal treatment of stage III NSCLC requires the joint work of a multidisciplinary team of expert physicians within the tumour committee. To improve the care of patients with stage III NSCLC, different scientific societies involved in the diagnosis and treatment of this disease have agreed to issue a series of recommendations that can contribute to homogenise the management of this disease, and ultimately to improve patient care.

1 September 2006 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
JEJulio Sánchez de Cos Escuín
Julio Sánchez de Cos Escuín
LSLuis Miravet Sorribes
Luis Miravet Sorribes
JAJosé Abal Arca
José Abal Arca
AAAna Núñez Ares
Ana Núñez Ares
JHJ. Hernández
J. Hernández
IHIgnacio Sánchez Hernández
Ignacio Sánchez Hernández

1 May 2014 in Lung Cancer
Verified
Journal Article
Closed access
JEJulio Sánchez de Cos Escuín
Julio Sánchez de Cos Escuín
JAJosé Abal Arca
José Abal Arca
RÍRosario Melchor Íñiguez
Rosario Melchor Íñiguez
LSLuis Miravet Sorribes
Luis Miravet Sorribes
AAAna Núñez Ares
Ana Núñez Ares
HRHelena Hernández Rodríguez
Helena Hernández Rodríguez

1 February 2008 in Lung Cancer
Verified
Journal Article
Closed access
JCJulio Sánchez de Cos
Julio Sánchez de Cos
LMLuis Miravet
Luis Miravet
JAJosé Abal
José Abal
ANAna Núñez
Ana Núñez
FMF. Javier Muñoz
F. Javier Muñoz
MAM. Ángel Alonso
M. Ángel Alonso